What is the Abeona Therapeutics Inc (ABEO) price today?

The price of Abeona Therapeutics Inc (ABEO) today is $5.68. This value reflects the latest market rate available on Pluang. Check the asset page for additional details such as 24-hour change, market trends, and trading volume.

What are the trading hours of US Stocks?

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.

Do I get a dividend from investing in US Stocks?

Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.

What is the fee for each transaction?

Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.

Trade on Pluang

One platform for all markets

Download

Investment

Features

Fees Safety

Academy

Pluang+

Home/Explore/US Market Price/Stocks/ABEO

Buy & Sell Abeona Therapeutics Inc (ABEO) – Abeona Therapeutics Inc Price Today

Overview Financials Technicals Analysis Corp Action About

24H

YTD

Aura AI Summary

ABEO trades at $5.63, up 4.65% with strong momentum following recent earnings beats. The stock shows compelling valuation metrics with a P/E of 5.33 and EV/EBITDA of 1.79, while profitability metrics appear elevated with a net income margin of 1,223.08% and ROE of 70.05%. Recent news highlights ZEVASKYN commercial launch progress with new treatment center activations and board appointments signaling operational expansion.

Outlook remains positive with analyst consensus at 'Buy' (66.7% of coverage) and ZEVASKYN's $4B+ revenue potential driving optimism. Key risks include execution of commercial launch, reliance on single product revenue, and insider selling activity. The combination of strong fundamentals and product momentum supports continued upside potential.

Read full analysis

Key Stats

Market Cap
$306.92M
Sector
Health
3M Drawdown
-21.67%
Enterprise Value
$140.49M
Dividend Yield
-
Typical Hold Time
0 days

$5.68

52W Low: $4.17

11 Nov 2025

52W High: $7.23

22 Aug 2025

Abeona Therapeutics Inc (ABEO) is currently valued at a market capitalization of $306.92M, with an enterprise value of $140.49M. Over the past 52 weeks, Abeona Therapeutics Inc has traded between a low of $4.17 and a high of $7.23, highlighting its annual price range. Over the past three months, Abeona Therapeutics Inc has recorded a drawdown of -21.67%, reflecting recent price volatility. On average, investors hold Abeona Therapeutics Inc for approximately 0 days, indicating typical investor behavior on the platform.

About Abeona Therapeutics Inc

Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.

Technical Indicators

Overall Summary

Bearish (7)Neutral (11)Bullish (9)

News

Globe Newswire1 year ago

U.S. FDA Approves ZEVASKYN™ (prademagene zamikeracel), the First and Only Cell-Based Gene Therapy for Patients with Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Globe Newswire1 year ago

Cell and Gene Therapies in Rare Disorders Market to Skyrocket Across the 7MM During the Forecast Period (2025–2034) | DelveInsight

Globe Newswire1 year ago

Global Mucopolysaccharidosis Treatment Market to Witness Robust Growth, Projected to Reach USD 5,014.5 Million by 2035 Growing at a CAGR of 5.9% | FMI

Globe Newswire2 year ago

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Globe Newswire2 year ago

Abeona Therapeutics to Present at the Jefferies Global Healthcare Conference

People also bought

US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

Market Cap
$306.92M
Sector
Health
3M Drawdown
-21.67%
Enterprise Value
$140.49M
Dividend Yield
-
Typical Hold Time
0 days

$5.68

52W Low: $4.17

11 Nov 2025

52W High: $7.23

22 Aug 2025

Let’s invest in this asset by signing up or download!

Buy & Sell Abeona Therapeutics Inc (ABEO) – Abeona Therapeutics Inc Price Today

Aura AI Summary

Key Stats

About Abeona Therapeutics Inc

People also bought

Key Stats

Invest

Features

Fees

Learn

Investment Clubs (Coming Soon)

Support

iOS App Store

Google Play Store